Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SERD Wars: Clinical Integration of Emerging Endocrine-Directed and Precision Therapies in Breast Cancer.

JCO oncology practice·2026
Same author

Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway.

Cancer research communications·2026
Same author

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

Nature communications·2026
Same author

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer.

Breast (Edinburgh, Scotland)·2026
Same author

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

NPJ precision oncology·2026

相关实验视频

Updated: Jun 21, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

乳腺癌的系统治疗方法

Chiara Corti1, Hemali Batra-Sharma2, Max Kelsten3

  • 1Dana Farber Cancer Institute, Harvard University, Boston, MA.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
|July 16, 2024
PubMed
概括

最近的乳腺癌治疗进展集中在基于病理反应的新辅助策略和个性化治疗上. 像免疫疗法这样的新药类和新疗法挑战了目前的治疗顺序,以获得更好的结果.

更多相关视频

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K

相关实验视频

Last Updated: Jun 21, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.6K

科学领域:

  • 在瘤学瘤学.
  • 翻译癌症研究 翻译癌症研究
  • 基因组医学是基因组医学.

背景情况:

  • 由于最近的治疗进展,乳腺癌的治疗结果得到了显著改善.
  • 转向新辅助策略和个性化后辅助治疗的转变在早期乳腺癌管理中是明显的.
  • 基因组学的进步提高了对乳腺癌生物学的理解,并确定了针对性治疗的关键分子标记物.

研究的目的:

  • 审查乳腺癌当前的治疗进展.
  • 讨论新辅助和辅助治疗策略的不断变化的格局.
  • 突出基因组医学和新药类对乳腺癌护理和测序挑战的影响.

主要方法:

  • 审查最近的临床试验和乳腺癌的治疗进展.
  • 从辅助方法过渡到新辅助方法的分析.
  • 在不同疾病阶段对基因组测定和向测序的评估.
  • 评估新型治疗药物,包括抗体与药物合物,免疫疗法和CDK4-6抑制剂.

主要成果:

  • 新辅助策略允许根据病理反应定制治疗,指导治疗后的决策.
  • 基因组分析有助于识别在辅助和高级环境中预测治疗效益的分子标记物.
  • 新的药物类别和重新定位的疗法正在被整合到 (新) 辅助环境中,扩大治疗选择.

结论:

  • 个性化治疗策略,通过病理反应和分子标记来告知,对于优化乳腺癌结果至关重要.
  • 像免疫疗法和CDK4-6抑制剂这样的新疗法在新辅助和辅助环境中的整合需要仔细考虑治疗顺序.
  • 对新型药物类和组合疗法的持续研究对于进一步改善乳腺癌生存率和生活质量至关重要.